Product NDC: | 0703-7041 |
Proprietary Name: | Haloperidol |
Non Proprietary Name: | Haloperidol |
Active Ingredient(s): | 5 mg/mL & nbsp; Haloperidol |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-7041 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076035 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020301 |
Package NDC: | 0703-7041-04 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-7041-04) > 1 mL in 1 VIAL, SINGLE-DOSE (0703-7041-01) |
NDC Code | 0703-7041-04 |
Proprietary Name | Haloperidol |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-7041-04) > 1 mL in 1 VIAL, SINGLE-DOSE (0703-7041-01) |
Product NDC | 0703-7041 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Haloperidol |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20020301 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | HALOPERIDOL LACTATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Typical Antipsychotic [EPC] |